Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2010
11/23/2010US7838505 using hybrid Hepatocyte Growth Factor (HGF) construct for prevention and treatment of ischemic and liver disorders
11/23/2010US7838290 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
11/23/2010US7838289 Assay utilizing multipotent adult stem cells
11/23/2010US7838023 Ethanamine, 2-L[5-oxido-4-phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]-N,N-bis[2-[[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]ethyl]-; cardiovascular diseases; inhibiting platelet aggregation, platelet adhesion caused by the exposure of blood to a medical device; abnormal cell proliferation
11/23/2010US7836883 Methods for treating rhinitis and conjunctivitis
11/23/2010CA2461068C Cell populations which co-express cd49c and cd90
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/23/2010CA2440014C Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
11/23/2010CA2438870C Novel inhibitors of formation of advanced glycation endproducts (ages)
11/23/2010CA2385150C Vascular coating composition
11/23/2010CA2377309C Compounds for the modulation of ppar.gamma. activity
11/23/2010CA2315271C Platelet derived growth factor (pdgf) nucleic acid ligand complexes
11/18/2010WO2010132657A1 Compositions and methods for treating ischemia and ischemia-reperfusion injury
11/18/2010WO2010132347A2 Docosahexaenoic acid for the treatment of heart failure
11/18/2010WO2010131910A2 Composition for improving blood circulation containing fermented tea, and pharmaceutical and health-food compositions comprising the same
11/18/2010WO2010131695A1 Modified double-stranded rna
11/18/2010WO2010131675A1 Polymer conjugate of bioactive substance having hydroxy group
11/18/2010WO2010131669A1 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
11/18/2010WO2010131033A1 Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm)
11/18/2010WO2010130869A1 Use of olive leaf extracts in a pharmaceutical composition for inducing angiogenesis and vasculogenesis
11/18/2010WO2010130796A1 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010WO2010130351A1 Micrornas as biomarkers and therapeutic targets for heart failure
11/18/2010WO2010130152A1 Pharmaceutical composition for treating cardiovascular disorder and use thereof
11/18/2010WO2010130063A1 The little molecule compound which used for promoting the stem cells hyperplasia and the use thereof
11/18/2010WO2010111626A3 Poly (adp-ribose) polymerase (parp) inhibitors
11/18/2010WO2010102171A3 Secreted ap2 and methods of inhibiting same
11/18/2010WO2010097501A3 A combination treatment of stroke
11/18/2010WO2010069605A3 Oxidized cardiolipin as a novel pro-inflammatory factor
11/18/2010US20100292345 Therapeutic uses of cannabigerol
11/18/2010US20100292344 Methods and Compositions for Treating Thalamocortical Dysrhythmia
11/18/2010US20100292335 Use of organic compounds
11/18/2010US20100292334 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
11/18/2010US20100292327 Treatment of aspirin resistance with betaine and/or betaine enriched molasses
11/18/2010US20100292320 Benzofuran anilide histone deacetylase inhibitors
11/18/2010US20100292319 Process for preparing benzofurans
11/18/2010US20100292314 Anti-angiogenic compositions and methods of use
11/18/2010US20100292313 Compositions and methods for treating ischemia and ischemia-reperfusion injury
11/18/2010US20100292296 Novel ligands that modulate rar receptors
11/18/2010US20100292286 Crystalline imidazole-5-carboxylic acid derivative
11/18/2010US20100292283 Novel phenyl-acetamide and phenyl-propionamide derivatives useful as potassium channel modulators
11/18/2010US20100292279 Bis-(Sulfonylamino) Derivatives in Therapy
11/18/2010US20100292278 Methods of treating vascular disease and injury
11/18/2010US20100292276 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010US20100292273 Cannabinoid Receptor Modulators
11/18/2010US20100292268 Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
11/18/2010US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses
11/18/2010US20100292244 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
11/18/2010US20100292235 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
11/18/2010US20100292234 Triazole fused heteroaryl compounds and methods of use thereof
11/18/2010US20100292233 Dihydro-1h-pyrrolo[1,2-a]indol-1-yl carboxylic acid derivatives which act as s1p1 agonists
11/18/2010US20100292229 Tryphostin-analogs for the treatment of cell proliferative diseases
11/18/2010US20100292225 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010US20100292215 11beta-hydroxysteroid dehydrogenase type 1 active compounds
11/18/2010US20100292213 Anti-Inflammatory Agents
11/18/2010US20100292212 New azacyclic derivatives
11/18/2010US20100292208 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010US20100292207 Substituted indazole derivatives active as kinase inhibitors
11/18/2010US20100292205 Pyrimidone Compounds As GSK-3 Inhibitors
11/18/2010US20100292204 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
11/18/2010US20100292197 Compositions and Methods for Increasing Telomerase Activity
11/18/2010US20100292192 Angiotensin ii receptor antagonists
11/18/2010US20100292188 Compounds Comprising A Cyclobutoxy Group
11/18/2010US20100292183 Tetracycline and uses thereof
11/18/2010US20100292172 Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same
11/18/2010US20100292142 Novel neurotrophic factors
11/18/2010US20100292134 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
11/18/2010US20100292133 Truncated glp-1 derivaties and their therapeutical use
11/18/2010US20100292132 Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent
11/18/2010US20100291628 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost
11/18/2010US20100291228 Scavenger of in vivo harmful reactive oxygen species and/or free radicals
11/18/2010US20100291217 Pharmaceutical compositions
11/18/2010US20100291216 Pharmaceutical compositions
11/18/2010US20100291211 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue
11/18/2010US20100291208 Controlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof
11/18/2010US20100291206 Oral dosage form
11/18/2010US20100291201 Coated pharmaceutical capsule dosage form
11/18/2010US20100291198 Compositions of phytosterols with enhanced bioavailability
11/18/2010US20100291191 Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
11/18/2010US20100291175 Polymers comprising amorphous terpolymers and semicrystalline blocks
11/18/2010US20100291170 Novel therapies for chronic renal failure
11/18/2010US20100291160 Pharmaceutical system for trans-membrane delivery
11/18/2010US20100291099 Novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, narc 25, 86604 and 32222 molecules and uses therefor
11/18/2010US20100291089 Ligand of regulating immune response, and use thereof in treating an immune response-related disease
11/18/2010US20100291080 Compositions and methods for tissue repair
11/18/2010US20100291064 Compounds and Methods for the Treatment of Vascular Disease
11/18/2010US20100291056 Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same
11/18/2010US20100291042 Multipotent stem cells and uses thereof
11/18/2010US20100291033 Albumin Fusion Proteins
11/18/2010US20100291028 Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases
11/18/2010US20100291027 Hyaluronic acid (ha) injection vehicle
11/18/2010US20100291021 Aliphatic prodrug linker
11/18/2010US20100291020 Novel compounds as dipeptidyl peptidase iv (dpp iv) inhibitors
11/18/2010DE102009022046A1 Entfärbte Extrakte der Pflanze Pandanus conoideus Discolored extracts of the plant Pandanus conoideus
11/18/2010CA2799087A1 Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm)
11/18/2010CA2761859A1 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010CA2761853A1 Benzoxazolone derivatives as aldosterone synthase inhibitors
11/18/2010CA2761798A1 Compositions and methods for treating ischemia and ischemia-reperfusion injury
11/17/2010EP2251339A2 Compounds
11/17/2010EP2251338A2 Organic compounds
11/17/2010EP2251337A1 Dihydropyridine calcium antagonist compounds, preparation methods and medical uses thereof
1 ... 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 ... 1595